Literature DB >> 23528346

Liver cancer: The promise of new approaches in the management of hepatocellular carcinoma--adding to the toolbox?

Katrina Ray.   

Abstract

Entities:  

Year:  2013        PMID： 23528346     DOI： 10.1038/nrgastro.2013.52

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  2 in total

1.  Therapeutically targeting glypican-3 via a conformation-specific single-domain antibody in hepatocellular carcinoma.

Authors:  Mingqian Feng; Wei Gao; Ruoqi Wang; Weizao Chen; Yan-Gao Man; William Douglas Figg; Xin Wei Wang; Dimiter S Dimitrov; Mitchell Ho
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-05       Impact factor: 11.205

2.  Tissue metabolomics of hepatocellular carcinoma: tumor energy metabolism and the role of transcriptomic classification.

Authors:  Diren Beyoğlu; Sandrine Imbeaud; Olivier Maurhofer; Paulette Bioulac-Sage; Jessica Zucman-Rossi; Jean-François Dufour; Jeffrey R Idle
Journal:  Hepatology       Date:  2013-05-08       Impact factor: 17.425
  2 in total
  5 in total

1.  Function and clinical potential of microRNAs in hepatocellular carcinoma.

Authors:  Lijuan Wang; Yongfang Yue; Xian Wang; Hongchuan Jin
Journal:  Oncol Lett       Date:  2015-09-29       Impact factor: 2.967

2.  Combination of exosomes and circulating microRNAs may serve as a promising tumor marker complementary to alpha-fetoprotein for early-stage hepatocellular carcinoma diagnosis in rats.

Authors:  Wei-hui Liu; Li-na Ren; Xing Wang; Tao Wang; Ning Zhang; Yuan Gao; Hao Luo; Nalu Navarro-Alvarez; Li-jun Tang
Journal:  J Cancer Res Clin Oncol       Date:  2015-02-28       Impact factor: 4.553

Review 3.  microRNA: a promising diagnostic biomarker and therapeutic target for hepatocellular carcinoma.

Authors:  Xiaofei Li; Wenjun Yang; Lianqing Lou; Yongxin Chen; Shuang Wu; Guoqiang Ding
Journal:  Dig Dis Sci       Date:  2014-01-04       Impact factor: 3.199

Review 4.  MicroRNAs dysregulation in hepatocellular carcinoma: Insights in genomic medicine.

Authors:  Iván Lyra-González; Laura E Flores-Fong; Ignacio González-García; David Medina-Preciado; Juan Armendáriz-Borunda
Journal:  World J Hepatol       Date:  2015-06-18

5.  In vivo antitumor activity evaluation of cancer vaccines prepared by various antigen forms in a murine hepatocellular carcinoma model.

Authors:  Chunfeng Si; Maolei Xu; Meiyu Lu; Yan Yu; Meizi Yang; Miaomiao Yan; Ling Zhou; Xiaoping Yang
Journal:  Oncol Lett       Date:  2017-10-11       Impact factor: 2.967
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.